Contact
searchSearch
HMP Global
Login

ADHD Education Center

Featured

Dr Rakesh Jain
Podcasts
Targeting Hyperactivity and Impulsivity in Adolescents: A Look at Viloxazine ER
04/17/2025
Rakesh Jain, MD, MPH, RD
Join Rakesh Jain, MD, MPH, as he explores the role of viloxazine extended-release (ER) in targeting hyperactivity and impulsivity in adolescents with ADHD.
Join Rakesh Jain, MD, MPH, as he explores the role of viloxazine extended-release (ER) in targeting hyperactivity and impulsivity in adolescents with ADHD.
Join Rakesh Jain, MD, MPH, as he...
04/17/2025
Psych Congress Network
Dr Greg Mattingly
Podcasts
Viloxazine ER: A New Era in ADHD Treatment?
04/17/2025
Greg Mattingly, MD
Join Greg Mattingly, MD, as he discusses the evolving ADHD treatment landscape, in particular extended-release viloxazine
Join Greg Mattingly, MD, as he discusses the evolving ADHD treatment landscape, in particular extended-release viloxazine
Join Greg Mattingly, MD, as he...
04/17/2025
Psych Congress Network
Viloxazine Molecule
News
Viloxazine ER: A Nonstimulant in ADHD Treatment
04/14/2025
Viloxazine ER is a nonstimulant medication for ADHD that has a unique mechanism of action compared to traditional stimulant medications, broadening the therapeutic landscape.
Viloxazine ER is a nonstimulant medication for ADHD that has a unique mechanism of action compared to traditional stimulant medications, broadening the therapeutic landscape.
Viloxazine ER is a nonstimulant...
04/14/2025
Psych Congress Network
a boy with adhd
News
Youth With Symptomatic ADHD More Likely to Use Nicotine and Tobacco Later On
02/27/2025
Jolynn Tumolo
US youths with higher levels of ADHD symptom severity had significantly higher odds of initiating e-cigarette, cigarette, and other tobacco use over a 9-year follow-up.
US youths with higher levels of ADHD symptom severity had significantly higher odds of initiating e-cigarette, cigarette, and other tobacco use over a 9-year follow-up.
US youths with higher levels of...
02/27/2025
Psych Congress Network
Study Offers Practical Recommendations to Improve Diagnosis and Care for Women With ADHD
News
Study Offers Practical Recommendations to Improve Diagnosis and Care for Women With ADHD
02/26/2025
Evi Arthur
A new mixed-methods study published in the Journal of Attention Disorders confirms this research and investigates the barriers to care women diagnosed with ADHD face, as well as what practical changes clinicians can make to create more...
A new mixed-methods study published in the Journal of Attention Disorders confirms this research and investigates the barriers to care women diagnosed with ADHD face, as well as what practical changes clinicians can make to create more...
A new mixed-methods study...
02/26/2025
Psych Congress Network
A child sleeps in bed on her stomach with her mouth hanging open
News
Loudness of Snoring May Indicate Greater Hyperactivity in Children and Adolescents
01/16/2025
Brionna Mendoza
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
Loudness of snoring, regardless...
01/16/2025
Psych Congress Network
Methylphenidate or Atomoxetine Maintenance Safe During Pregnancy
News
Methylphenidate or Atomoxetine Maintenance Safe During Pregnancy
01/08/2025
Evi Arthur
Maintenance of methylphenidate or atomoxetine may be safe during pregnancy, according to recent systematic review and meta-analysis results published in JAMA Network Open. 
Maintenance of methylphenidate or atomoxetine may be safe during pregnancy, according to recent systematic review and meta-analysis results published in JAMA Network Open. 
Maintenance of methylphenidate...
01/08/2025
Psych Congress Network
A young child wears goofy sunglasses and smiles
News
Pandemic’s Effect on Youth Mental Health Varied Across Different Groups
09/04/2024
Jolynn Tumolo
A recently published study in JAMA Network Open presents a nuanced picture of how the COVID-19 pandemic affected youth mental health.
A recently published study in JAMA Network Open presents a nuanced picture of how the COVID-19 pandemic affected youth mental health.
A recently published study in...
09/04/2024
Psych Congress Network
a young child lays in bed with a teddy bear and rubs their eyes
News
Childhood Sleep Issues May Signal ADHD Symptoms in Preadolescence
08/14/2024
Jolynn Tumolo
In 3 pediatric cohorts in Spain, children with sleep problems at ages 8 and 9 were at increased risk of attention-deficit/hyperactivity disorder (ADHD) symptoms in preadolescence. Researchers published their findings in the European Journal...
In 3 pediatric cohorts in Spain, children with sleep problems at ages 8 and 9 were at increased risk of attention-deficit/hyperactivity disorder (ADHD) symptoms in preadolescence. Researchers published their findings in the European Journal...
In 3 pediatric cohorts in Spain,...
08/14/2024
Psych Congress Network
pediatric adhd
News
Several Treatments Effective in Youth With ADHD, but Evidence Strongest for Medication
05/31/2024
Jolynn Tumolo
While treatments that improve attention-deficit/hyperactivity disorder (ADHD) in children and adolescents are diverse and growing, medications have the strongest evidence base for improved outcomes.
While treatments that improve attention-deficit/hyperactivity disorder (ADHD) in children and adolescents are diverse and growing, medications have the strongest evidence base for improved outcomes.
While treatments that improve...
05/31/2024
Psych Congress Network
ADHD Medication Use, Particularly Stimulants, Tied to Fewer Hospitalizations
News
ADHD Medication Use, Particularly Stimulants, Tied to Fewer Hospitalizations
05/01/2024
Evi Arthur
In a recent cohort study, use of medication for ADHD, especially lisdexamphetamine and other stimulants, was associated with fewer hospitalizations, and lower suicidal behavior, according to results published in JAMA Network Open. 
In a recent cohort study, use of medication for ADHD, especially lisdexamphetamine and other stimulants, was associated with fewer hospitalizations, and lower suicidal behavior, according to results published in JAMA Network Open. 
In a recent cohort study, use of...
05/01/2024
Psych Congress Network

Videos

Drs Mattingly, Price, Amann Part 3
Videos
Navigating ADHD Care Forward: The Future of ADHD
01/15/2024
In this roundtable discussion featuring a panel of experts, Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann focus on the evolving future of the ADHD landscape and address current unmet needs in ADHD treatment for both adult and...
In this roundtable discussion featuring a panel of experts, Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann focus on the evolving future of the ADHD landscape and address current unmet needs in ADHD treatment for both adult and...
In this roundtable discussion...
01/15/2024
Psych Congress Network
Drs Mattingly, Price, Amann Part 1
Videos
ADHD Unmasked: Current ADHD Treatment Landscape
01/15/2024
In this roundtable discussion featuring a panel of experts, Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann delve into the evolving landscape of ADHD treatment. The panelists discuss current treatment options, including...
In this roundtable discussion featuring a panel of experts, Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann delve into the evolving landscape of ADHD treatment. The panelists discuss current treatment options, including...
In this roundtable discussion...
01/15/2024
Psych Congress Network
Drs Mattingly, Price, Amann Part 2
Videos
Real-World Data Deep Dive: Viloxazine ER Compared With Atomoxetine for ADHD Study
12/12/2023
In this roundtable discussion featuring a panel of experts, Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann explore key findings from the real-world study comparing viloxazine ER with atomoxetine for ADHD treatment in adult and...
In this roundtable discussion featuring a panel of experts, Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann explore key findings from the real-world study comparing viloxazine ER with atomoxetine for ADHD treatment in adult and...
In this roundtable discussion...
12/12/2023
Psych Congress Network
Greg Mattingly, MD, and Elizabeth Judd, NP, MHS
Videos
How to Incorporate Non-Stimulants Into ADHD Treatment Plans
06/05/2023
Greg Mattingly, MD, and Elizabeth Judd, NP, MHS, discuss how clinicians can incorporate non-stimulant medication into their ADHD treatment plans.
Greg Mattingly, MD, and Elizabeth Judd, NP, MHS, discuss how clinicians can incorporate non-stimulant medication into their ADHD treatment plans.
Greg Mattingly, MD, and...
06/05/2023
Psych Congress Network
Manpreet Singh
Videos
Pediatric ADHD: Proper Diagnosis, Stimulant Therapy
12/16/2021
Manpreet Singh, MD, MS, discusses introducing stimulant therapy for ADHD management, differentiating pediatric ADHD from mood disorders, and gender or ethnic bias during diagnosis.
Manpreet Singh, MD, MS, discusses introducing stimulant therapy for ADHD management, differentiating pediatric ADHD from mood disorders, and gender or ethnic bias during diagnosis.
Manpreet Singh, MD, MS,...
12/16/2021
Psych Congress Network
Manpreet Singh
Videos
Dr Singh Offers "Clinical Clues" to Distinguish Pediatric ADHD From Mood Disorders
12/07/2021
Manpreet K Singh, MD, MS, offers "clinical clues" to clinicians on how to distinguish ADHD from primary mood disorders or other conditions and also discusses comorbid conditions in pediatric ADHD. 
Manpreet K Singh, MD, MS, offers "clinical clues" to clinicians on how to distinguish ADHD from primary mood disorders or other conditions and also discusses comorbid conditions in pediatric ADHD. 
Manpreet K Singh, MD, MS, offers...
12/07/2021
Psych Congress Network
Manpreet Singh
Videos
Treatment of ADHD Throughout the Holiday Season
11/22/2021
Manpreet K Singh, MD, MS, director, offers tips for clinicians to maintain manage expectations and the best possible care for patients with ADHD throughout the holiday season.
Manpreet K Singh, MD, MS, director, offers tips for clinicians to maintain manage expectations and the best possible care for patients with ADHD throughout the holiday season.
Manpreet K Singh, MD, MS,...
11/22/2021
Psych Congress Network
Dr. Andrew J. Cutler
Videos
New ADHD Medications Allow For More Personalized Treatment Plans
06/09/2021
Andrew J. Cutler, MD, discusses the newer medications in development and recently approved to treat ADHD. It is “a very exciting time” as there a number of newer treatment options, allowing clinicians to personalize treatment for their...
Andrew J. Cutler, MD, discusses the newer medications in development and recently approved to treat ADHD. It is “a very exciting time” as there a number of newer treatment options, allowing clinicians to personalize treatment for their...
Andrew J. Cutler, MD, discusses...
06/09/2021
Psych Congress Network
Dr Rakesh Jain on Nonstimulant Treatment Options for Pediatric ADHD
Videos
Dr Rakesh Jain on Nonstimulant Treatment Options for Pediatric ADHD
02/17/2021
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses an article he cowrote on nonstimulant treatment options for pediatric attention-deficit/hyperactivity disorder (ADHD).
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses an article he cowrote on nonstimulant treatment options for pediatric attention-deficit/hyperactivity disorder (ADHD).
Psych Congress Steering...
02/17/2021
Psych Congress Network
Headshot of Snoben Kuruvila
Videos
Emerging Rapid-Acting Intervention Options for the Treatment of MDD
04/24/2025
Following his insightful session at Psych Congress 2024, Snoben Kuruvila, MPAS, PA-C, sat down with Psych Congress Network to discuss emerging developments in major depressive disorder (MDD) treatment.
Following his insightful session at Psych Congress 2024, Snoben Kuruvila, MPAS, PA-C, sat down with Psych Congress Network to discuss emerging developments in major depressive disorder (MDD) treatment.
Following his insightful session...
04/24/2025
Psych Congress Network
headshot of Dr Craig Chepke
Videos
Effective Communication Strategies for Introducing LAIs in Telemedicine Settings
04/16/2025
Craig Chepke, MD, DFAPA
In this video, Craig Chepke, MD, DFAPA, discusses effective communication strategies clinicians can use when introducing long-acting injectable (LAI) antipsychotics to patients for the treatment of schizophrenia.
In this video, Craig Chepke, MD, DFAPA, discusses effective communication strategies clinicians can use when introducing long-acting injectable (LAI) antipsychotics to patients for the treatment of schizophrenia.
In this video, Craig Chepke, MD,...
04/16/2025
Psych Congress Network
Kristian Dambrino, MSN
Videos
When Monotherapy Doesn’t Work: Treatment Resistance in Tardive Dyskinesia
04/08/2025
Kristian Dambrino, MSN, APRN, PMHNP
Psych Congress Faculty Member Kristian Dambrino, DNP, PMHNP-BC, dives into the nuances of prescribing vesicular monoamine transporter 2 (VMAT-2) inhibitors for the long-term management of TD.
Psych Congress Faculty Member Kristian Dambrino, DNP, PMHNP-BC, dives into the nuances of prescribing vesicular monoamine transporter 2 (VMAT-2) inhibitors for the long-term management of TD.
Psych Congress Faculty Member...
04/08/2025
Psych Congress Network
Examining Novel Treatment Methods in Schizophrenia
Videos
Examining Novel Treatment Methods in Schizophrenia
02/25/2025
Christoph U. Correll, MD
In this discussion, Christoph Correll, MD, professor of psychiatry at the Zucker School of Medicine, delves into the groundbreaking FDA approval of xanomeline/tropsium chloride, a novel treatment for schizophrenia that moves beyond...
In this discussion, Christoph Correll, MD, professor of psychiatry at the Zucker School of Medicine, delves into the groundbreaking FDA approval of xanomeline/tropsium chloride, a novel treatment for schizophrenia that moves beyond...
In this discussion, Christoph...
02/25/2025
Psych Congress Network
Steven Chan, MD, MBA, FAPA, FAMIA
Videos
Barriers and Misconceptions to Digital Therapeutic Integration
02/14/2025
Steven Chan, MD, MBA
In this video, Steven Chan, MD, MBA, FAPA, FAMIA, Psych Congress Steering Committee, explains some of the barriers that virtual clinicians should anticipate when weighing digital therapeutic options for major depressive disorder (MDD)...
In this video, Steven Chan, MD, MBA, FAPA, FAMIA, Psych Congress Steering Committee, explains some of the barriers that virtual clinicians should anticipate when weighing digital therapeutic options for major depressive disorder (MDD)...
In this video, Steven Chan, MD,...
02/14/2025
Psych Congress Network
Steven Chan, MD, MBA, FAPA, FAMIA
Videos
Tapping into Neuroplasticity Through Digital Therapeutics for MDD
02/10/2025
Steven Chan, MD, MBA
Steven Chan, MD, MBA, FAPA, FAMIA, explains how telehealth providers can explore and adopt digital therapeutics for their virtual practices.
Steven Chan, MD, MBA, FAPA, FAMIA, explains how telehealth providers can explore and adopt digital therapeutics for their virtual practices.
Steven Chan, MD, MBA, FAPA,...
02/10/2025
Psych Congress Network
Brooke Kempf, PMHNP-BC
Videos
Improving Patient Outcomes With Early Initiation of LAIs
02/05/2025
Brooke Kempf, MSN, PMHNP-BC
What role do long-acting injectables (LAIs) play in improving long-term outcomes for patients with schizophrenia? In this discussion, Brooke Kempf, PMHNP-BC, highlights the benefits of early LAI initiation, from reducing relapse rates and...
What role do long-acting injectables (LAIs) play in improving long-term outcomes for patients with schizophrenia? In this discussion, Brooke Kempf, PMHNP-BC, highlights the benefits of early LAI initiation, from reducing relapse rates and...
What role do long-acting...
02/05/2025
Psych Congress Network
Edward Kaftarian, MD.
Videos
Treating Substance Use Disorder via Telehealth
01/30/2025
Edward Kaftarian, MD
Edward Kaftarian, MD, shares his insights on the clinical, legal, and technological factors that impact virtual care for SUD.
Edward Kaftarian, MD, shares his insights on the clinical, legal, and technological factors that impact virtual care for SUD.
Edward Kaftarian, MD, shares...
01/30/2025
Psych Congress Network
Brooke Kempf
Videos
Addressing Misconceptions About LAI Antipsychotics
01/06/2025
Brooke Kempf, MSN, PMHNP-BC
Kempf emphasizes the power of patient education, addressing myths, and involving families to ease the daily medication burden. 
Kempf emphasizes the power of patient education, addressing myths, and involving families to ease the daily medication burden. 
Kempf emphasizes the power of...
01/06/2025
Psych Congress Network
Desiree Matthews, PMHNP-BC, CEO
Videos
How to Navigate Insurance When Treating Tardive Dyskinesia
01/06/2025
Desiree Matthews, PHMNP-BC
In this video, Desiree Matthews, PMHNP-BC, discusses how to navigate insurance policies when treating tardive dyskinesia.
In this video, Desiree Matthews, PMHNP-BC, discusses how to navigate insurance policies when treating tardive dyskinesia.
In this video, Desiree Matthews,...
01/06/2025
Psych Congress Network

News Articles

Viloxazine Molecule
News
Viloxazine ER: A Nonstimulant in ADHD Treatment
04/14/2025
Viloxazine ER is a nonstimulant medication for ADHD that has a unique mechanism of action compared to traditional stimulant medications, broadening the therapeutic landscape.
Viloxazine ER is a nonstimulant medication for ADHD that has a unique mechanism of action compared to traditional stimulant medications, broadening the therapeutic landscape.
Viloxazine ER is a nonstimulant...
04/14/2025
Psych Congress Network
a boy with adhd
News
Youth With Symptomatic ADHD More Likely to Use Nicotine and Tobacco Later On
02/27/2025
Jolynn Tumolo
US youths with higher levels of ADHD symptom severity had significantly higher odds of initiating e-cigarette, cigarette, and other tobacco use over a 9-year follow-up.
US youths with higher levels of ADHD symptom severity had significantly higher odds of initiating e-cigarette, cigarette, and other tobacco use over a 9-year follow-up.
US youths with higher levels of...
02/27/2025
Psych Congress Network
Study Offers Practical Recommendations to Improve Diagnosis and Care for Women With ADHD
News
Study Offers Practical Recommendations to Improve Diagnosis and Care for Women With ADHD
02/26/2025
Evi Arthur
A new mixed-methods study published in the Journal of Attention Disorders confirms this research and investigates the barriers to care women diagnosed with ADHD face, as well as what practical changes clinicians can make to create more...
A new mixed-methods study published in the Journal of Attention Disorders confirms this research and investigates the barriers to care women diagnosed with ADHD face, as well as what practical changes clinicians can make to create more...
A new mixed-methods study...
02/26/2025
Psych Congress Network
A child sleeps in bed on her stomach with her mouth hanging open
News
Loudness of Snoring May Indicate Greater Hyperactivity in Children and Adolescents
01/16/2025
Brionna Mendoza
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
Loudness of snoring, regardless...
01/16/2025
Psych Congress Network
Methylphenidate or Atomoxetine Maintenance Safe During Pregnancy
News
Methylphenidate or Atomoxetine Maintenance Safe During Pregnancy
01/08/2025
Evi Arthur
Maintenance of methylphenidate or atomoxetine may be safe during pregnancy, according to recent systematic review and meta-analysis results published in JAMA Network Open. 
Maintenance of methylphenidate or atomoxetine may be safe during pregnancy, according to recent systematic review and meta-analysis results published in JAMA Network Open. 
Maintenance of methylphenidate...
01/08/2025
Psych Congress Network
A young child wears goofy sunglasses and smiles
News
Pandemic’s Effect on Youth Mental Health Varied Across Different Groups
09/04/2024
Jolynn Tumolo
A recently published study in JAMA Network Open presents a nuanced picture of how the COVID-19 pandemic affected youth mental health.
A recently published study in JAMA Network Open presents a nuanced picture of how the COVID-19 pandemic affected youth mental health.
A recently published study in...
09/04/2024
Psych Congress Network
a young child lays in bed with a teddy bear and rubs their eyes
News
Childhood Sleep Issues May Signal ADHD Symptoms in Preadolescence
08/14/2024
Jolynn Tumolo
In 3 pediatric cohorts in Spain, children with sleep problems at ages 8 and 9 were at increased risk of attention-deficit/hyperactivity disorder (ADHD) symptoms in preadolescence. Researchers published their findings in the European Journal...
In 3 pediatric cohorts in Spain, children with sleep problems at ages 8 and 9 were at increased risk of attention-deficit/hyperactivity disorder (ADHD) symptoms in preadolescence. Researchers published their findings in the European Journal...
In 3 pediatric cohorts in Spain,...
08/14/2024
Psych Congress Network
pediatric adhd
News
Several Treatments Effective in Youth With ADHD, but Evidence Strongest for Medication
05/31/2024
Jolynn Tumolo
While treatments that improve attention-deficit/hyperactivity disorder (ADHD) in children and adolescents are diverse and growing, medications have the strongest evidence base for improved outcomes.
While treatments that improve attention-deficit/hyperactivity disorder (ADHD) in children and adolescents are diverse and growing, medications have the strongest evidence base for improved outcomes.
While treatments that improve...
05/31/2024
Psych Congress Network
ADHD Medication Use, Particularly Stimulants, Tied to Fewer Hospitalizations
News
ADHD Medication Use, Particularly Stimulants, Tied to Fewer Hospitalizations
05/01/2024
Evi Arthur
In a recent cohort study, use of medication for ADHD, especially lisdexamphetamine and other stimulants, was associated with fewer hospitalizations, and lower suicidal behavior, according to results published in JAMA Network Open. 
In a recent cohort study, use of medication for ADHD, especially lisdexamphetamine and other stimulants, was associated with fewer hospitalizations, and lower suicidal behavior, according to results published in JAMA Network Open. 
In a recent cohort study, use of...
05/01/2024
Psych Congress Network
A Black infant with bantu knots holds an alphabet letter block
News
Genetic Links Between Vocabulary and Later-Life ADHD Shift Over Infancy and Toddlerhood
04/01/2024
Jolynn Tumolo
A larger span of spoken words was genetically linked with an increased risk of attention-deficit/hyperactivity disorder (ADHD) and more ADHD symptoms in infants, but by toddlerhood the genetic relationship was reversed.
A larger span of spoken words was genetically linked with an increased risk of attention-deficit/hyperactivity disorder (ADHD) and more ADHD symptoms in infants, but by toddlerhood the genetic relationship was reversed.
A larger span of spoken words...
04/01/2024
Psych Congress Network
open and spilled bottle of pills
News
Beta-Blockers Ineffective for Treating Psychological Symptoms of Anxiety
04/24/2025
Maria Mantas
A systematic review found no evidence of a beneficial effect from beta-blockers in treating anxiety symptoms in patients with social phobia or panic disorder with or without agoraphobia compared to either placebo or benzodiazepines.
A systematic review found no evidence of a beneficial effect from beta-blockers in treating anxiety symptoms in patients with social phobia or panic disorder with or without agoraphobia compared to either placebo or benzodiazepines.
A systematic review found no...
04/24/2025
Psych Congress Network
tipped over pill bottle with white pills spilling out
News
Fewer Than Half of Medicaid Managed Care Plans Cover All Medications For AUD
04/22/2025
Maria Mantas
Fewer than half of all Medicaid managed care plans (MCPs) covered all 4 US Food and Drug Administration (FDA)–approved medications for the treatment of alcohol use disorder (AUD), a cross-sectional study published in JAMA Network Open found.
Fewer than half of all Medicaid managed care plans (MCPs) covered all 4 US Food and Drug Administration (FDA)–approved medications for the treatment of alcohol use disorder (AUD), a cross-sectional study published in JAMA Network Open found.
Fewer than half of all Medicaid...
04/22/2025
Psych Congress Network
Neurons in the brain
News
Risk Factors for Late-Onset Epilepsy in Patients With Cognitive Decline Identified
04/21/2025
Jolynn Tumolo
Late-onset epilepsy (LOE) risk factors in people with cognitive decline include Parkinson disease, early-onset dementia (before age 60), poor cognition, stroke or transient ischemic attacks, Alzheimer disease, and the APOE4 allele.
Late-onset epilepsy (LOE) risk factors in people with cognitive decline include Parkinson disease, early-onset dementia (before age 60), poor cognition, stroke or transient ischemic attacks, Alzheimer disease, and the APOE4 allele.
Late-onset epilepsy (LOE) risk...
04/21/2025
Neurology
strand of DNA
News
Genetic Liability for Schizophrenia May Affect Traumatic Brain Injury Associations
04/21/2025
Jolynn Tumolo
A genetic liability for schizophrenia and other mental disorders appears to factor into the associations between traumatic brain injury and mental disorder and suicide, according to study findings.
A genetic liability for schizophrenia and other mental disorders appears to factor into the associations between traumatic brain injury and mental disorder and suicide, according to study findings.
A genetic liability for...
04/21/2025
Psych Congress Network
injection for schizophrenia treatment
News
Antipsychotic Sedation Peaks in First 2 Weeks, Emphasizing Importance of Early Monitoring
04/21/2025
Maria Mantas
A meta-analysis of randomized controlled trials (RCTs) of antipsychotic monotherapy for the acute phase of schizophrenia and schizoaffective disorder (SSD) found that sedation onset peaked within the first 2 weeks of treatment initiation.
A meta-analysis of randomized controlled trials (RCTs) of antipsychotic monotherapy for the acute phase of schizophrenia and schizoaffective disorder (SSD) found that sedation onset peaked within the first 2 weeks of treatment initiation.
A meta-analysis of randomized...
04/21/2025
Psych Congress Network
older woman with depression
News
Evidence Lacking for TRD Treatment Effectiveness in Older Adults, Review Finds
04/16/2025
Maria Mantas
A recent systematic review found weak quality evidence to support the effectiveness of several commonly prescribed pharmacological and non-pharmacological interventions for treatment-resistant depression (TRD) in older adults. 
A recent systematic review found weak quality evidence to support the effectiveness of several commonly prescribed pharmacological and non-pharmacological interventions for treatment-resistant depression (TRD) in older adults. 
A recent systematic review found...
04/16/2025
Psych Congress Network
Viloxazine Molecule
News
Viloxazine ER: A Nonstimulant in ADHD Treatment
04/14/2025
Viloxazine ER is a nonstimulant medication for ADHD that has a unique mechanism of action compared to traditional stimulant medications, broadening the therapeutic landscape.
Viloxazine ER is a nonstimulant medication for ADHD that has a unique mechanism of action compared to traditional stimulant medications, broadening the therapeutic landscape.
Viloxazine ER is a nonstimulant...
04/14/2025
Psych Congress Network
an assortment of pills spilled out on a yellow table
News
Inpatient Addiction Consultation Service Promotes MOUD in Patients with OUD
04/14/2025
Jolynn Tumolo
According to randomized clinical trial findings, patients with opioid use disorder (OUD) who received inpatient addiction consultation service were more likely to initiate medication for OUD (MOUD) compared to those who received usual care.
According to randomized clinical trial findings, patients with opioid use disorder (OUD) who received inpatient addiction consultation service were more likely to initiate medication for OUD (MOUD) compared to those who received usual care.
According to randomized clinical...
04/14/2025
Psych Congress Network
Hormonal Contraceptive Pills
News
Post Partum Hormonal Contraception Use Linked with Heightened Depression Risk
04/09/2025
Jolynn Tumolo
The initiation of hormonal contraception post partum was associated with an immediate increase in depression risk in first-time mothers in Denmark, according to a study published in JAMA Network Open.
The initiation of hormonal contraception post partum was associated with an immediate increase in depression risk in first-time mothers in Denmark, according to a study published in JAMA Network Open.
The initiation of hormonal...
04/09/2025
Psych Congress Network
A woman taking a pill
News
New Study Finds Quetiapine More Effective Than Lithium in Reducing Treatment-Resistant Depression Symptoms
04/09/2025
Maria Mantas
Quetiapine may be more clinically effective than lithium as an augmentation option for reducing symptoms of treatment-resistant depression (TRD), a type of major depressive disorder (MDD), according to a recent study.
Quetiapine may be more clinically effective than lithium as an augmentation option for reducing symptoms of treatment-resistant depression (TRD), a type of major depressive disorder (MDD), according to a recent study.
Quetiapine may be more...
04/09/2025
Psych Congress Network

Podcasts

Dr Rakesh Jain
Podcasts
Targeting Hyperactivity and Impulsivity in Adolescents: A Look at Viloxazine ER
04/17/2025
Rakesh Jain, MD, MPH, RD
Join Rakesh Jain, MD, MPH, as he explores the role of viloxazine extended-release (ER) in targeting hyperactivity and impulsivity in adolescents with ADHD.
Join Rakesh Jain, MD, MPH, as he explores the role of viloxazine extended-release (ER) in targeting hyperactivity and impulsivity in adolescents with ADHD.
Join Rakesh Jain, MD, MPH, as he...
04/17/2025
Psych Congress Network
Dr Greg Mattingly
Podcasts
Viloxazine ER: A New Era in ADHD Treatment?
04/17/2025
Greg Mattingly, MD
Join Greg Mattingly, MD, as he discusses the evolving ADHD treatment landscape, in particular extended-release viloxazine
Join Greg Mattingly, MD, as he discusses the evolving ADHD treatment landscape, in particular extended-release viloxazine
Join Greg Mattingly, MD, as he...
04/17/2025
Psych Congress Network
Dr Rakesh Jain
Podcasts
Targeting Hyperactivity and Impulsivity in Adolescents: A Look at Viloxazine ER
04/17/2025
Rakesh Jain, MD, MPH, RD
Join Rakesh Jain, MD, MPH, as he explores the role of viloxazine extended-release (ER) in targeting hyperactivity and impulsivity in adolescents with ADHD.
Join Rakesh Jain, MD, MPH, as he explores the role of viloxazine extended-release (ER) in targeting hyperactivity and impulsivity in adolescents with ADHD.
Join Rakesh Jain, MD, MPH, as he...
04/17/2025
Psych Congress Network
Dr Greg Mattingly
Podcasts
Viloxazine ER: A New Era in ADHD Treatment?
04/17/2025
Greg Mattingly, MD
Join Greg Mattingly, MD, as he discusses the evolving ADHD treatment landscape, in particular extended-release viloxazine
Join Greg Mattingly, MD, as he discusses the evolving ADHD treatment landscape, in particular extended-release viloxazine
Join Greg Mattingly, MD, as he...
04/17/2025
Psych Congress Network
Rakesh and Craig
Podcasts
Weighing the Options: Medication, Lifestyle, and the Path to Wellness
03/26/2025
Rakesh Jain, MD, MPH, RD; Craig Chepke, MD, DFAPA
In this episode, Dr Rakesh Jain and Dr Craig Chepke explore medication-induced weight gain in schizophrenia treatment and how clinicians can help patients take control of their health, mind, and body.
In this episode, Dr Rakesh Jain and Dr Craig Chepke explore medication-induced weight gain in schizophrenia treatment and how clinicians can help patients take control of their health, mind, and body.
In this episode, Dr Rakesh Jain...
03/26/2025
Psych Congress Network
psych congress family and friends podcast
Podcasts
Gut Feelings: Tackling Medication-Induced Nausea
02/05/2025
Join Dr Craig Chepke and D. Rakesh Jain in this episode of the Psych Congress Family & Friends Podcast as they tackle a topic that affects so many patients receiving psychiatric treatment: nausea!
Join Dr Craig Chepke and D. Rakesh Jain in this episode of the Psych Congress Family & Friends Podcast as they tackle a topic that affects so many patients receiving psychiatric treatment: nausea!
Join Dr Craig Chepke and D....
02/05/2025
Psych Congress Network
psych congress family and friends podcast
Podcasts
A New Beginning, and a Fond Farewell
01/06/2025
Craig Chepke, MD, DFAPA; Rakesh Jain, MD, MPH, RD
Join Dr Rakesh Jain and Dr Craig Chepke for a discussion of feelings surrounding the recent passing of Dr Vladimir Maletic leads to an exploration of a topic near and dear to Dr Maletic's heart—the role of norepinephrine in clinical practice.
Join Dr Rakesh Jain and Dr Craig Chepke for a discussion of feelings surrounding the recent passing of Dr Vladimir Maletic leads to an exploration of a topic near and dear to Dr Maletic's heart—the role of norepinephrine in clinical practice.
Join Dr Rakesh Jain and Dr Craig...
01/06/2025
Psych Congress Network
psych congress family and friends podcast
Podcasts
Welcome to Psych Congress Family & Friends Hosted by Rakesh Jain and Craig Chepke
01/06/2025
Rakesh Jain, MD, MPH, RD; Craig Chepke, MD, DFAPA
Introducing our new psychiatry and psychopharmacology podcast aimed at enhancing your clinical practice in an approachable and heartfelt way, hosted by Rakesh Jain, MD, MPH, and Craig Chepke, MD, DFAPA. Subscribe now!
Introducing our new psychiatry and psychopharmacology podcast aimed at enhancing your clinical practice in an approachable and heartfelt way, hosted by Rakesh Jain, MD, MPH, and Craig Chepke, MD, DFAPA. Subscribe now!
Introducing our new psychiatry...
01/06/2025
Psych Congress Network
Drs Podesta and Carbray
Podcasts
Managing Comorbid Bipolar Disorder & SUD: Treatment and Communication
07/22/2024
Arwen Podesta, MD; Julie A. Carbray, PhD, APRN
Drs Podesta and Carbray examine available treatments, recommended strategies, and how clinicians can better communicate with patients with this comorbidity.
Drs Podesta and Carbray examine available treatments, recommended strategies, and how clinicians can better communicate with patients with this comorbidity.
Drs Podesta and Carbray examine...
07/22/2024
Psych Congress Network
Drs Chepke and Jain
Podcasts
Differentiating Between BPD and Bipolar Disorder in Clinical Practice
05/14/2024

With Rakesh Jain, MD, and Craig Chepke, MD

With Rakesh Jain, MD, and Craig Chepk...
Rakesh Jain, MD, and Craig Chepke, MD, continue their Psych Congress Regionals discussion and examine how to tease apart symptoms of borderline personality disorder from symptoms of bipolar disorder, and how to get to the right diagnosis.
Rakesh Jain, MD, and Craig Chepke, MD, continue their Psych Congress Regionals discussion and examine how to tease apart symptoms of borderline personality disorder from symptoms of bipolar disorder, and how to get to the right diagnosis.
Rakesh Jain, MD, and Craig...
05/14/2024
Psych Congress Network
Drs Chepke and Jain
Podcasts
Managing Adverse Effects and Medication Changes in Bipolar Disorder
05/07/2024
In this podcast, Drs Craig Chepke and Rakesh Jain discuss switching medications and avoiding adverse effects like weight gain in bipolar disorder treatment.
In this podcast, Drs Craig Chepke and Rakesh Jain discuss switching medications and avoiding adverse effects like weight gain in bipolar disorder treatment.
In this podcast, Drs Craig...
05/07/2024
Psych Congress Network
Amber Hoberg, MSN, APRN, PMHNP-BC, Jonathan Meyer, MD, and Saundra Jain, PsyD
Podcasts
Your Questions Answered: Optimizing Tardive Dyskinesia Care
12/05/2023
Amber Hoberg, MSN, APRN, PMHNP-BC; Saundra Jain, MA, PsyD, LPC; Jonathan Meyer, MD
Clinical experts Amber Hoberg, MSN, APRN, PMHNP-BC, and Jonathan Meyer, MD, answer audience questions on their session, "More than Skin Deep: Examining the Full Impact of Tardive Dyskinesia," presented at Psych Congress Regionals.
Clinical experts Amber Hoberg, MSN, APRN, PMHNP-BC, and Jonathan Meyer, MD, answer audience questions on their session, "More than Skin Deep: Examining the Full Impact of Tardive Dyskinesia," presented at Psych Congress Regionals.
Clinical experts Amber Hoberg,...
12/05/2023
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Sign Up

Psych Congress Network Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use